Prabhu Thirusangu

1.1k total citations
35 papers, 879 citations indexed

About

Prabhu Thirusangu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Prabhu Thirusangu has authored 35 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Prabhu Thirusangu's work include Synthesis and biological activity (10 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Cell death mechanisms and regulation (6 papers). Prabhu Thirusangu is often cited by papers focused on Synthesis and biological activity (10 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Cell death mechanisms and regulation (6 papers). Prabhu Thirusangu collaborates with scholars based in India, United States and China. Prabhu Thirusangu's co-authors include B.T. Prabhakar, Shaukath Ara Khanum, B.R. Vijay Avin, V. Lakshmi Ranganatha, V. Vigneshwaran, Viji Shridhar, Upasana Ray, T. Prashanth, Julie Staub and Derek B. Oien and has published in prestigious journals such as Cancer Research, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Prabhu Thirusangu

35 papers receiving 869 citations

Peers

Countries citing papers authored by Prabhu Thirusangu

Since Specialization

Citations

This map shows the geographic impact of Prabhu Thirusangu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabhu Thirusangu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabhu Thirusangu more than expected).

Fields of papers citing papers by Prabhu Thirusangu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prabhu Thirusangu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabhu Thirusangu. The network helps show where Prabhu Thirusangu may publish in the future.

Co-authorship network of co-authors of Prabhu Thirusangu

This figure shows the co-authorship network connecting the top 25 collaborators of Prabhu Thirusangu. A scholar is included among the top collaborators of Prabhu Thirusangu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabhu Thirusangu. Prabhu Thirusangu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction 2023 ·Oncogene ·Upasana Ray, Prabhu Thirusangu, Ling Jin, Yinan Xiao, (unknown), Julie Staub, Courtney L. Erskine, Keith Dredge, Edward Hammond, Matthew S. Block, Scott H. Kaufmann, Jamie N. Bakkum‐Gamez, Viji Shridhar	7
2	Steroidal alkaloid solanidine impedes hypoxia-driven ATM phosphorylation to switch on anti-angiogenesis in lung adenocarcinoma 2023 ·Phytomedicine ·(unknown), (unknown), (unknown), Prabhu Thirusangu, B.R. Vijay Avin, Suchetha Kumari, Y. L. Ramachandra, B.T. Prabhakar	8
3	Antiproliferative pharmacophore azo-hydrazone analogue BT-1F exerts death signalling pathway targeting STAT3 in solid tumour 2022 ·Pharmacological Reports ·(unknown), (unknown), (unknown), Zabiulla Zabiulla, (unknown), Prabhu Thirusangu, Riaz Mahmood, Suchetha Kumari, (unknown), Shaukath Ara Khanum, B.T. Prabhakar	9
4	Exploiting LRRC15 as a Novel Therapeutic Target in Cancer 2022 ·Cancer Research ·Upasana Ray, (unknown), Prabhu Thirusangu, James W. Purcell, Nagarajan Kannan, Viji Shridhar	31
5	PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma 2022 ·Oncogene ·Prabhu Thirusangu, Upasana Ray, Sayantani Sarkar Bhattacharya, Derek B. Oien, Ling Jin, Julie Staub, Nagarajan Kannan, Julian R. Molina, Viji Shridhar	52
6	Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization 2021 ·Journal of Experimental & Clinical Cancer Research ·Upasana Ray, Debarshi Roy, Ling Jin, Prabhu Thirusangu, Julie Staub, Yinan Xiao, (unknown), Andrea E. Wahner Hendrickson, Grace Cullen, Krista M. Goergen, Ann L. Oberg, Viji Shridhar	12
7	Anti-neoplastic pharmacophore benzophenone-1 coumarin (BP-1C) targets JAK2 to induce apoptosis in lung cancer 2021 ·APOPTOSIS ·(unknown), (unknown), Prabhu Thirusangu, (unknown), (unknown), V. Vigneshwaran, Jurica Novak, (unknown), Y. L. Ramachandra, (unknown), Shaukath Ara Khanum, B.T. Prabhakar	7
8	Synthesis of coumarin analogs appended with quinoline and thiazole moiety and their apoptogenic role against murine ascitic carcinoma 2019 ·Biomedicine & Pharmacotherapy ·T. Prashanth, B.R. Vijay Avin, Prabhu Thirusangu, V. Lakshmi Ranganatha, B.T. Prabhakar, Joya Chandra, Shaukath Ara Khanum	50
9	Repurposing quinacrine for treatment-refractory cancer 2019 ·Seminars in Cancer Biology ·Derek B. Oien, (unknown), Upasana Ray, Prabhu Thirusangu, Eleftheria Kalogera, Viji Shridhar	69
10	The tumor antagonistic steroidal alkaloid Solanidine prompts the intrinsic suicidal signal mediated DFF-40 nuclear import and nucleosomal disruption 2018 ·Life Sciences ·(unknown), V. Vigneshwaran, Prabhu Thirusangu, Riaz Mahmood, B.T. Prabhakar	18
11	The anti-invasive role of novel synthesized pyridazine hydrazide appended phenoxy acetic acid against neoplastic development targeting matrix metallo proteases 2017 ·Biomedicine & Pharmacotherapy ·Yasser Hussein Eissa Mohammed, Prabhu Thirusangu, Zabiulla Zabiulla, V. Vigneshwaran, (unknown), Shaukath Ara Khanum	26
12	The Novel 4-Phenyl-2-Phenoxyacetamide Thiazoles modulates the tumor hypoxia leading to the crackdown of neoangiogenesis and evoking the cell death 2017 ·European Journal of Medicinal Chemistry ·Yasser Hussein Eissa Mohammed, (unknown), Prabhu Thirusangu, Mohammed Al‐Ghorbani, B.T. Prabhakar, Shaukath Ara Khanum	33
13	Scutellarein antagonizes the tumorigenesis by modulating cytokine VEGF mediated neoangiogenesis and DFF-40 actuated nucleosomal degradation 2017 ·Biochemical and Biophysical Research Communications ·Prabhu Thirusangu, V. Vigneshwaran, B.R. Vijay Avin, Rakesh Heer, (unknown), B.T. Prabhakar	31
14	The latex sap of the ‘Old World Plant’ Lagenaria siceraria with potent lectin activity mitigates neoplastic malignancy targeting neovasculature and cell death 2016 ·International Immunopharmacology ·V. Vigneshwaran, Prabhu Thirusangu, (unknown), V. Krishna, Siddanakoppalu N. Pramod, B.T. Prabhakar	25
15	Synthesis and antiproliferative activity of benzophenone tagged pyridine analogues towards activation of caspase activated DNase mediated nuclear fragmentation in Dalton’s lymphoma 2016 ·Bioorganic Chemistry ·Mohammed Al‐Ghorbani, Prabhu Thirusangu, (unknown), (unknown), (unknown), B.T. Prabhakar, Shaukath Ara Khanum	28
16	A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression 2016 ·Biochemical Pharmacology ·Prabhu Thirusangu, V. Vigneshwaran, V. Lakshmi Ranganatha, B.R. Vijay Avin, Shaukath Ara Khanum, Riaz Mahmood, K Jayashree, B.T. Prabhakar	37
17	BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation 2016 ·Angiogenesis ·Prabhu Thirusangu, V. Vigneshwaran, T. Prashanth, B.R. Vijay Avin, (unknown), Rakesh Heer, Shaukath Ara Khanum, Riaz Mahmood, B.T. Prabhakar	41
18	Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development 2016 ·Bioorganic Chemistry ·Mohammed Al‐Ghorbani, (unknown), (unknown), Prabhu Thirusangu, B.T. Prabhakar, Shaukath Ara Khanum	20
19	Synthesis and evaluation of novel benzophenone-thiazole derivatives as potent VEGF-A inhibitors 2014 ·European Journal of Medicinal Chemistry ·T. Prashanth, Prabhu Thirusangu, B.R. Vijay Avin, V. Lakshmi Ranganatha, B.T. Prabhakar, Shaukath Ara Khanum	37
20	DAO-9 (2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazole) exhibits p53 induced apoptogenesis through caspase-3 mediated endonuclease activity in murine carcinoma 2014 ·Biomedicine & Pharmacotherapy ·(unknown), Prabhu Thirusangu, B.R. Vijay Avin, V. Vigneshwaran, (unknown), (unknown), V. Lakshmi Ranganatha, Shaukath Ara Khanum, B.T. Prabhakar	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact